Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is one of the most commonly reported experiences in the first weeks of semaglutide treatment, and it is a recognised side effect listed in the Wegovy patient information leaflet. Most people who feel tired on semaglutide find it settles within a few weeks as the body adjusts. That said, not all tiredness has the same cause, and understanding the difference matters. These medicines are prescription-only and require ongoing clinical assessment — a prescriber should know if fatigue is affecting your daily life.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common assumption is that feeling worn out on Wegovy means the drug is doing something intense to the body — metabolising fat at speed, perhaps, or suppressing hunger so aggressively that energy crashes follow. It is a tidy story, but not quite accurate.
Fatigue during semaglutide treatment is more often downstream of appetite suppression than a direct drug effect in itself. When you eat noticeably less, your total energy and nutrient intake drops. If protein falls short, the body has less raw material for muscle repair and basic cellular work. If fluids drop alongside (nausea can make drinking feel unappealing) mild dehydration compounds the feeling of heaviness. The NHS medicines information on semaglutide lists fatigue alongside the more familiar gastrointestinal effects, reflecting that it appears in trial data at a meaningful rate without being the dominant complaint.
The practical implication: tiredness in the first few weeks is common and often manageable with small dietary adjustments (prioritising protein at each meal and keeping fluid intake steady) rather than assuming something is wrong. If your appetite is so suppressed that eating at all feels difficult, that is worth raising with a prescriber rather than pushing through.
If you have been managing well on your current dose and tiredness reappears after stepping up, you are not imagining a pattern. It is a recognisable one. The body needs a period of adjustment each time semaglutide is titrated upward, and fatigue often clusters in the days immediately following a new pen.
For most people this settles within one to two weeks. If you find yourself in the middle of that adjustment window during an already demanding stretch (say, returning to full weeks after a holiday, or starting a new dose in a particularly pressured month at work) the tiredness can feel more pronounced simply because your baseline reserves are lower. That is not a sign to stop; it is a reason to protect sleep and be realistic about what the next few days will feel like.
The detail worth tracking is direction of travel. Fatigue that eases progressively over two weeks is adjustment. Fatigue that does not lift, or that worsens, points toward something that needs clinical attention, whether that is the medicine itself, nutritional insufficiency, or a coincident health change.
Understanding the full side-effect profile of Wegovy can help you distinguish what is expected from what needs investigation.
Persistent exhaustion after four weeks, or tiredness accompanied by other symptoms, should not simply be attributed to the treatment without assessment. A few specific scenarios matter.
Severe or worsening gastrointestinal symptoms (repeated vomiting, persistent diarrhoea) can lead to dehydration and electrolyte depletion quickly, which produces fatigue alongside more obvious symptoms. If that combination is present, contact a healthcare professional promptly rather than waiting it out.
Separately, some people starting semaglutide are also managing other conditions whose own symptoms can mimic or amplify drug-related tiredness. Hypothyroidism, iron-deficiency anaemia and low vitamin B12 all cause fatigue; they do not conveniently pause while you are on a new medicine. If blood tests have not been done recently and fatigue is a feature, it is worth asking your GP or prescriber whether basic checks are appropriate.
There is also the question of sleep quality. Semaglutide is sometimes used by people with obstructive sleep apnoea, where weight reduction can itself change sleep patterns during treatment, occasionally for better, occasionally creating a temporary adjustment period. Fatigue specifically tied to Wegovy is worth examining from multiple angles rather than assuming a single cause.
It is also sensible to be aware of the broader safety picture: our page on the Wegovy blindness risk covers what is currently known about vision-related concerns, so you can weigh up the evidence alongside other side effects when speaking with your prescriber. The MHRA Yellow Card scheme allows patients to report side effects directly, which matters for post-marketing safety monitoring on medicines like Wegovy that carry a Black Triangle (▼) status.
Managing tiredness well on semaglutide is largely about protecting the basics your body needs when appetite suppression is significant. Protein first at each meal (even a small one) helps preserve muscle and steadier energy. Hydration takes conscious effort when you are not hungry or thirsty; plain water rather than caffeinated drinks is the more reliable choice through the adjustment period.
Strength or resistance activity, even light, is widely recommended alongside GLP-1 treatment to protect muscle mass, and some people find it supports energy levels once the initial adjustment phase has passed. Discuss the timing and type of activity with your prescriber if fatigue is making exercise feel impossible, that is a useful data point for your clinical review.
If you are weighing up whether semaglutide is right for you, the Wegovy treatment overview covers eligibility, what to expect, and how the prescription process works. For those further along (thinking about costs and what different services include) comparing Wegovy prices in the UK explains what a transparent private prescription should cover. And if nausea is running alongside the tiredness, guidance on nausea during Wegovy treatment addresses that pattern directly.
Tiredness in the early weeks is not a reason to stop. Tiredness that does not follow the expected pattern is a reason to speak to someone. Our prescribers are available seven days a week for aftercare, and no question is too small to raise.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.